secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2024-12-23T23:59:59+00:00
Accession:  0001104659-24-131322
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics closes $16.1M private placement of stock and warrants
-------------------------------------------------------------------------

- Gross proceeds ~$16.1M from sale of 1,783,805 shares, Series A warrants (5,031,250 shares at $4.00/sh), and pre-funded warrants (3,248,445 shares at $0.001/sh).
- Closed December 23, 2024; net proceeds for general corporate purposes and working capital.
- Company must seek stockholder approval for warrant share issuance within 90 days; ~27% of stockholders agreed to vote in favor.
- Registration rights agreement requires resale registration statement filed by January 14, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465924131322/0001104659-24-131322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465924131322/tm2431905d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-131322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer